#glp1drugs — Public Fediverse posts

https://www.europesays.com/dk/76609/ Novo sees comeback as weight-loss pill boom revives investor confidence – Firstpost #DenmarkPharma #EliLilly #Foundayo #GLP1Drugs #HealthcareStocks #NovoNordisk #NovoShares #ObesityDrugs #ObesityTreatmentMarket #ozempic #PeptideTherapies #PharmaNews #WegovyPill #WeightLossDrugCompetition #WeightLossPill

https://www.europesays.com/ie/432041/ Weight loss drugs are reshaping US agriculture and food industry #Agriculture #AppetiteSuppression #CropDemand #Éire #FoodIndustry #GLP1Drugs #Health #IE #Ireland #Medication #NutrientDenseMeals #Restaurants #WeightLoss

https://www.europesays.com/dk/53576/ Eli Lilly Gets Speedy FDA Nod for Oral GLP-1 Drug, a Competitor to New Novo Nordisk Pill #ClinicalTrials #EliLilly #FDA #Foundayo #GLP1Drugs #NovoNordisk #Obesity #WeightLoss

https://www.europesays.com/ie/415252/ Government tightens oversight of GLP-1 drugs, flags risks amid rising demand; key details | India News #BreakingNews #ChronicDisease #DrugRegulation #Éire #GLP1Drugs #GoogleNews #GovernmentAdvisory #GovernmentOfIndia #Health #IE #India #IndiaNews #IndiaNewsToday #InsulinProduction #Ireland #MedicalSupervision #Medication #ObesityMedication #SideEffectsOfGLP1 #TodayNews #Type2DiabetesTreatment

https://www.europesays.com/uk/864651/ Government tightens oversight of GLP-1 drugs, flags risks amid rising demand; key details | India News #BreakingNews #ChronicDisease #DrugRegulation #GLP1Drugs #GoogleNews #GovernmentAdvisory #GovernmentOfIndia #Health #India #IndiaNews #IndiaNewsToday #InsulinProduction #MedicalSupervision #Medication #ObesityMedication #SideEffectsOfGLP1 #TodayNews #Type2DiabetesTreatment #UK #UnitedKingdom

https://www.europesays.com/ie/399745/ Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices #AffordableTreatment #Éire #GenericMedicines #GLP1Drugs #Health #IE #IndianPharma #Ireland #Medication #semaglutide #Type2Diabetes #WeightLossInjection

https://www.europesays.com/dk/37556/ Short Seller Who Bet Against Hims & Hers Now Says Its CEO ‘Wiped The Floor’ With Novo Nordisk #AndrewDudumHims #GLP1Compounding #GLP1Drugs #Hims&HersHealth #HimsNovoDispute #HIMSStock #HunterbrookShortHims #KathrynBeiserEliLilly #NovoNordisk #OzempicWegovyPartnershipHims

Despite political setbacks and misinformation, scientists worldwide made significant advances in conservation, human origins, medical ethics, genetics and metabolism. https://www.japantimes.co.jp/commentary/2025/12/30/world/science-made-incredible-breakthroughs/?utm_medium=Social&utm_source=mastodon #commentary #worldnews #health #science #nasa #ryukyuislands #fat #ozempic #glp1drugs

The Economist's 2026 forecast: AI bubble warning flashes red, China capitalizes on US isolationism, weight-loss pills rival surgery, and geothermal could solve renewables' baseload problem. The polycrisis intensifies.
https://theurb.co/world-ahead-2026

#GlobalTrends #EconomicForecast #Geopolitics #AI #TheEconomist #InternationalRelations #ChinaUSRelations #GeothermalEnergy #GLP1Drugs #Europe #BondMarket #Polycrisis #GreyZoneWarfare #FederalReserve #BRICS #EnhancedGames #EnergyTransition #News #Obesity

The Economist's 2026 forecast: AI bubble warning flashes red, China capitalizes on US isolationism, weight-loss pills rival surgery, and geothermal could solve renewables' baseload problem. The polycrisis intensifies.
https://theurb.co/world-ahead-2026

#GlobalTrends #EconomicForecast #Geopolitics #AI #TheEconomist #InternationalRelations #ChinaUSRelations #GeothermalEnergy #GLP1Drugs #Europe #BondMarket #Polycrisis #GreyZoneWarfare #FederalReserve #BRICS #EnhancedGames #EnergyTransition #News #Obesity

The Economist's 2026 forecast: AI bubble warning flashes red, China capitalizes on US isolationism, weight-loss pills rival surgery, and geothermal could solve renewables' baseload problem. The polycrisis intensifies.
https://theurb.co/world-ahead-2026

#GlobalTrends #EconomicForecast #Geopolitics #AI #TheEconomist #InternationalRelations #ChinaUSRelations #GeothermalEnergy #GLP1Drugs #Europe #BondMarket #Polycrisis #GreyZoneWarfare #FederalReserve #BRICS #EnhancedGames #EnergyTransition #News #Obesity

The Economist's 2026 forecast: AI bubble warning flashes red, China capitalizes on US isolationism, weight-loss pills rival surgery, and geothermal could solve renewables' baseload problem. The polycrisis intensifies.
https://theurb.co/world-ahead-2026

#GlobalTrends #EconomicForecast #Geopolitics #AI #TheEconomist #InternationalRelations #ChinaUSRelations #GeothermalEnergy #GLP1Drugs #Europe #BondMarket #Polycrisis #GreyZoneWarfare #FederalReserve #BRICS #EnhancedGames #EnergyTransition #News #Obesity

The Economist's 2026 forecast: AI bubble warning flashes red, China capitalizes on US isolationism, weight-loss pills rival surgery, and geothermal could solve renewables' baseload problem. The polycrisis intensifies.
https://theurb.co/world-ahead-2026

#GlobalTrends #EconomicForecast #Geopolitics #AI #TheEconomist #InternationalRelations #ChinaUSRelations #GeothermalEnergy #GLP1Drugs #Europe #BondMarket #Polycrisis #GreyZoneWarfare #FederalReserve #BRICS #EnhancedGames #EnergyTransition #News #Obesity

https://www.europesays.com/ie/145486/ Want to live longer? How new drugs, AI and daily habits can extend lifespan #Alzheimer's #cancer #CardiovascularDisease #DrEricTopol #Éire #genomics #GLP1Drugs #Health #HowToAgeWell #IE #ImmuneSystem #inflammation #Ireland #LifestylePlus #MedicalData #MultiModalAI #NeurodegenerativeDisease #PredictingDisease #ScrippsResearch #SuperAgers:AnEvidenceBasedApproachToLongevity

Wall Street turns bearish on McDonald’s as Redburn Atlantic issues a rare ‘sell’ rating, citing weight-loss drug trends and inflation, with shares hitting a 12-year losing streak.
#YonhapInfomax #McDonalds #SellRating #GLP1Drugs #WallStreet #RevenueImpact #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=67004

Novo Nordisk will lose patent protection for semaglutide in China next year, opening the market to up to 20 biosimilar and generic competitors amid intensifying competition.
#YonhapInfomax #NovoNordisk #Semaglutide #PatentExpiry #ChinaPharmaceuticalMarket #GLP1Drugs #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=65853

Hims & Hers stock plummets 22% as FDA bans its GLP-1 generic drug, impacting the company's recent growth and market performance
#YonhapInfomax #HimsHers #StockPlunge #FDA #GLP1Drugs #GenericDrugBan #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=52221